Brokerages Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Price Target at $950.76
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the twenty-six analysts that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, eighteen have issued a buy rating […]
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the twenty-six analysts that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, eighteen have issued a buy rating […]
